ACB anti-doping committee to hear charge today
The Australian Cricket Board's Anti-Doping Committee will meet at 2.30 pm today (19 April) in Melbourne at the ACB Offices, 90 Jolimont Street, Jolimont to hear a charge arising from a drug test recorded by West Australian player, Duncan Spencer.
In accordance with the ACB's Anti-Doping Policy, the hearing has been convened to hear the charge following advice the ACB received from the Australian Sports Drug Agency (ASDA) on 2 April that Spencer had tested positive to the banned anabolic steroid, Nandrolone.
Under the ACB's policy, if found guilty of a doping offence Spencer faces a minimum penalty of a two year suspension from interstate and international cricket.
The ACB's Anti-Doping Committee for this hearing is:
- Mr Justice William Gillard (Supreme Court of Victoria (Chair))
- Dr Susan White (Australian Sports Drug Medical Advisory Committee)
- Mr Justice Glen Williams (Queensland Court of Appeal)
Spencer played six Mercantile Mutual games for the Western Warriors this season after returning to interstate cricket following a back injury.
He was tested as part of the ACB's independent, random and unannounced drug testing program following the Mercantile Mutual Cup Final between Western Australia and New South Wales on 25 February 2001 and played no representative cricket after the test result was recorded.
The hearing will be conducted in private and is expected to take several hours after which ACB Chief Executive, Malcolm Speed, and Duncan Spencer will address the media on the outcome.